Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:45 am Sale | 2026-06-30 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 2,520,359 4.000% | -1,355,677 (-34.98%) | Filing History |
| 2026-05-15 1:47 pm Sale | 2026-03-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 3,876,036 6.200% | -1,139,924 (-22.73%) | Filing History |
| 2026-02-17 8:52 pm Sale | 2025-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 5,015,960 9.000% | -511,568 (-9.25%) | Filing History |
| 2025-11-28 4:23 pm Sale | 2025-11-26 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 5,527,528 9.900% | -960,017 (-14.80%) | Filing History |
| 2024-02-13 4:18 pm Purchase | 2023-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 6,487,545 11.700% | 262,198 (+4.21%) | Filing History |
| 2023-02-13 5:13 pm Purchase | 2022-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 6,225,347 11.300% | 174,103 (+2.88%) | Filing History |
| 2022-02-25 4:43 pm Purchase | 2021-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 6,051,244 11.000% | 6,051,244 (New Position) | Filing History |